Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vilaprisan versus placebo and ulipristal for uterine fibroids
NL-OMON42795Phase 2Active, not recruiting
- Sponsor
- Bayer
- Start
- Aug 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of vilaprisan in Fibromyoma (LM) (7 arms), sponsored by Bayer. Started Aug 2015; status: active, not recruiting.
02
Drugs
vilaprisan
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on NL-OMON42795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42795.